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A B S T R A C T
The excellent conductivity matching of two-dimensional (2D) semiconductor nanomaterials (e.g. MoS2) with
cancer cell plays an important role in ultrasensitive label-free impedimetric detection of circulating tumor cells
(CTC) (< 1 cell/mL). Firstly, 2D semiconductor materials (e.g. 2D MoS2) exfoliated by folic acid (FA) is used to
construct MoS2/FA-modified gold electrode (AuE/MoS2/FA). Then, the fabricated electrode is applied for HeLa
cell detection in a linear range from 1 to 105 cell/mL with a detection limit of 0.43 cell/mL (S/N=3). The
detection mechanism of high sensitivity might be owing to the electric conductivity matching of MoS2 (0.14 S/
m) to cancer cell (0.13–0.23 S/m). A negligible conductivity change induced by cancer cell will produce a large
impedance change of semiconductor electrode. Furthermore, HeLa cells dispersed in healthy blood samples are
detected by suggested cytosensor in a linear range from 50 to 105 cell/mL with a detection limit of 52.24 cell/mL
(S/N=2). Finally, we demonstrate that the cytosensor is capable of differentiating patients of cervical and liver
cancers by the real CTC analysis from healthy control.
1. Introduction
Developing feasible methods with sufficient sensitivity and specifi-
city to detect circulating tumor cells (CTC) have a strong impact in
clinic by repressing redundant therapies (Ahmed et al., 2017; Lee et al.,
2013; Paterlini-Brechot and Benali, 2007; Plaks et al., 2013; Qian et al.,
2015). Existing methods for CTC analysis often need laborious experi-
mental steps, stringent laboratory conditions, expensive instruments
and so on (Brindle, 2008; Kim et al., 2013; Shen et al., 2017). The la-
bel−free detection of CTC by electrochemical method, without any
specialized labeling reagent, would greatly simplify the analysis tech-
nique and accelerate its implementation for rapid CTC capture and
diagnostics (Hwang et al., 2017; Liu et al., 2010; Xu et al., 2016). As
one of non-invasive methods for the characterization of cells, electro-
chemical impedance spectroscopy (EIS) has been used to provide the
frequency-dependent electrical properties of cells involved with cellular
physiology or morphology (Feng et al., 2011; Gajasinghe et al., 2016;
Green et al., 2016; Hu et al., 2013b; Nwankire et al., 2015; Skourou
et al., 2004; Wang et al., 2012). The design of electrode with inter-
mediate conductivity and a bionic structure containing biomolecules
would play an important role in improving the sensitivity of electro-
chemical detection (Sun et al., 2014). Therefore, it remains a challenge
to design a sensing element with excellent electric conductivity
matching to cancer cell for producing ultrasensitive detection of CTC in
clinic.
Compared with excellent conductors, such as graphene (104 S/m),
the advantage of medium electrical conductivity for semiconductor
could be helpful in constructing impedimetric approach (Bardhan et al.,
2017; Feng et al., 2012; Maltez-da Costa et al., 2012; Yoon et al., 2013;
Yoon et al., 2016). Two-dimensional (2D) semiconductor (e.g. MoS2),
with the mobility of at least 200 cm2 V−1 s−1 for a 0.15 eV bandgap
(Backes et al., 2015; Ghatak et al., 2011; Lopez-Sanchez et al., 2013;
Radisavljevic et al., 2011; Tan et al., 2017; Voiry et al., 2015) and its
close electron conductivity to cancer cells (0.14 vs 0.13–0.23 S/m) (Das
et al., 2014; Laufer et al., 2012), together with easily functionalized
surface, would completely meet our requirement for electrode design.
Herein, taken 2D MoS2 as an example, we developed an alternating
current (AC) impedimetric approach for label-free and ultrasensitive
detection of CTCs based on the conductivity matching of 2D MoS2 with
cancer cell. In our investigations, 2D MoS2 stabilized with folic acid
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(MoS2/FA) was used as the signal indicator and assembled on the gold
electrode (AuE) surface to produce MoS2/FA-modified AuE (AuE/
MoS2/FA), yielding an amplified signal to improve detection sensitivity.
FA was immobilized on the MoS2 surface as the outmost layer to se-
lectively recognize folate receptor (FR)-riched HeLa cells. The as-pre-
pared cytosensor presented high sensitivity and selectivity for the de-
tection of FR-riched HeLa cells. Furthermore, MoS2/FA-anchored
electrode was used to detect the real blood samples from patients of
liver and cervical cancer with satisfactory results. Such sensing strate-
gies provide a new way for importing 2D MoS2 techniques into the non-
invasion cytosensing systems.
2. Experimental
2.1. Preparation of AuE/MoS2/FA electrodes
Prior to the modification, the AuE (Φ=3mm) was polished with
0.3 and 0.05 μm alumina slurry, rinsed thoroughly with doubly distilled
water between each polishing step, then washed successively with 1:1
nitric acid, ethanol, and doubly distilled water in an ultrasonic bath and
dried with a high-purity nitrogen steam. 10 μL of MoS2/FA suspension
(100 μg/mL) and 1 μL of 0.5% Nafion mixture were casted on the pre-
treated AuE and dried under air. To avoid nonspecific adsorption of
serum proteins, AuE was immersed in 1% BSA solution for 5min and
then washed by 10mM PBS (pH=7.4) to produce AuE/MoS2/FA
electrodes. The modified electrodes were stored in air prior to use.
2.2. Cancer cell detection by impedance measurement
Alternating current impedance measurements were performed on an
electrochemical workstation (CHI660C, CH Instrument) using a 3.0 M
KCl–Ag/AgCl as the reference electrode, a platinum (Pt) wire as the
auxiliary electrode and AuE/MoS2/FA electrodes as the work elec-
trodes. Electrodes were immersed in 10mL of fresh solutions of cell
suspensions. A mixture of penicillin and streptomycin (1% v/v, Sigma)
was added to the cell suspension to prevent microbial contamination.
The impedance was then measured with time continuously at 10 Hz.
The data were processed by dividing the impedance measured at given
time intervals (Rt) by the initial impedance (R0) of the electrode im-
mediately following immersion into the cell suspensions, and designed
as relative impedance (Z=Rt/R0). All electrodes after incubation in
cells were washed twice by PBS to remove the natural sedimentation of
cells due to gravity. Impedance measurements were also performed on
the AUTOLAB PGSTAT302N electrochemical workstation.
2.3. Analysis of clinical samples
Sixteen tubes of fresh whole blood samples anticoagulated with
heparin were obtained from the Department of Radiation Oncology of
The First Affiliated Hospital of Xiamen University. Blood samples were
kept at 4 °C before use. The impedance measurements were performed
accroding to the same procedure as pure samples except that AuE/
MoS2/FA electrodes was immersed in PBS solution when fresh whole
blood samples were added.
3. Results and discussion
Detection principle shown in Fig. 1 is that cancer cells immobilized
on the 2D semiconductor materials essentially hinder unrestricted
current flow from the electrode into the bulk electrolyte and thereby
increase the overall electrode impedance when HeLa cells attach on the
surface of AuE/SC/FA (Fig. 1a). The conductivity of electrode with
intermediate conductivity (0.14 S/m) will decrease 50% when a cancer
cell (0.13–0.23 S/m) is immobilized on the electrode surface, which is
very sensitive to detect cancer cell. On the contrary, this weak change is
unobvious for the electrode with too high or low conductivity. For the
electrode with too high conductivity (e.g. graphene of 104 S/m), the
conductivity change of 0.13–0.23 S/m induced by a cancer cell cannot
be showed well (about 1000 cells to produce 1% change), thus resulting
in the relativily high detection limit. At the same time, the electrode
with too low conductivity (e.g. 106 Ω), the resistance change of 10Ω
induced by a cancer cells cannot be showed well (about 1000 cells to
produce 1% change), also resulting in a relativily high detection limit.
The negatively charged SC/FA would decrease the nonspecific binding
of normal cells due to electrostatic repulsion between the negatively
charged cell membrane and negatively charged electrode surface,
which resulted in unchanged impedance (Fig. 1b and c).
3.1. Preparation and characterization of MoS2/FA
The layered structure of purchased bulk MoS2 was confirmed by
scanning electron microscope (SEM), energy dispersive X−ray (EDX)
spectrum and X-ray diffraction (XRD, Fig. S1) pattern. FA containing
several amine and amide groups, carboxyl groups and benzene rings
shows stronger binding affinity to MoS2 than two neighboring MoS2
layers (0.21 eV) (Guan et al., 2015), benefiting the exfoliation process.
Furthermore, FA guarantees the FA-modified electrodes to selectively
capture FR-rich tumor cells in our system (Low et al., 2008; Malara
et al., 2014). Therefore, FA was selected as the functional group. The
MoS2/FA production parameters are optimized to be 30 h, 0.5mg/mL
FA and pH 8 (Figs. S2–4). UV–vis spectra (Fig. S5a) shows that a few
absorption peaks at 372, 444, 609 and 672 nm appeared for MoS2/FA
compared to bulk MoS2. The peaks at 280 and 372 nm are attributed to
the π−π transition of FA (Dantola et al., 2010). The XRD pattern of
MoS2/FA (Fig. S5b) shows that a [002] orientation is observed and
some characteristic peaks disappear compared to bulk MoS2, which
indicates that bulk MoS2 had been successfully exfoliated. Transmission
electron microscope (TEM) images (Figs. S6a and b) of exfoliated MoS2
show that the as-obtained MoS2/FA is extremely thin 2D flake with the
size of 100–200 nm. The structure of MoS2/FA nanosheets was con-
firmed by selected area electron diffraction (SAED) pattern and HRTEM
image (Figs. S6b–c). The SAED pattern with [100] zone axis (Fig. S6b
inset) and corresponding HRTEM image (Fig. S6c) reveal the hexagonal
lattice structure with the lattice spacing of 0.27 nm and 0.62 nm as-
signed to the (100) and (002) planes of MoS2/FA, respectively. Raman
spectrum shows that the two characteristic peaks at 380 and 410 cm−1
are assigned to E12g and A1g modes of the bulk MoS2. Compared with the
bulk MoS2, MoS2/FA sample shows an obvious blue shift of E12g peak
(Fig. S6d) and no obvious shift of A1g peak, indicating that the MoS2
was successfully exfoliated with a thickness of 4–10 layers (Li et al.,
2012a), which was further confirmed by Atomic Force Microscope
(AFM, Fig. S6e). The Mo and S elements uniformly distribute in sheets,
indicating the MoS2/FA had been successfully prepared (Fig. S7). The
Fourier transform infra−red (FTIR) spectra shows that C=O, C=C and
C–N groups could be seen in MoS2/FA and FA (Fig. S8), but not in bulk
MoS2. Thermal gravimetric analysis (TGA) indicates that MoS2 was
coated by FA molecules with loading as high as 27.9% (Fig. S6f), which
could help in constructing highly sensitive biosensors.
3.2. Electrochemical impedance detection of HeLa cells
The AuE/MoS2/FA was prepared by dropping the MoS2/FA ink onto
gold electrode. Cyclic voltammetry and impedance behavior of various
cells on AuE/MoS2/FA show that it is possible to detect FR-rich HeLa
cells by AuE/MoS2/FA electrode with electrochemical impedance
method (Fig. S9 and Table S1). Then, the mean change in impedance at
a fixed frequency (10 Hz) was recorded for HeLa cell with different
concentrations and plotted against time (Fig. 2a). The relative im-
pedance was produced by dividing the measured impedance at given
time by the initial impedance of the AuE/MoS2/FA electrode. The re-
lative impedance curve indicates an increase against time and could be
fitted to a second-order exponential growth (Eq. (1)), and the fittings of
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exponential association match perfectly with our experimental data
(Fig. 2b), resulting from that the detection of HeLa cells on AuE/MoS2/
FA electrode has attachment and immobilization steps and is under
mixed mass transport and kinetic control.
Z(t)= Z0+ΔZ1[1−exp(−t/τ1)]+ΔZ2[1−exp(−t/τ2)] (1)
In Eq. (1), Z(t) represents the relative impedance at time of t, Z0
represents the relative impedance at t= 0, ΔZ1 and ΔZ2 represent re-
lative impedances resulted from the cell attachment and binding, τ1 and
Fig. 1. Schematic diagram of the electrochemical
impedance cytosensor with SC/FA probe for de-
tection of CTC. (a) The fabrication of AuE/SC/FA for
CTC capture. (b) Schematic model of HeLa cell
binding with folic acid (FA) and repelling normal cell
(NC) on a negatively charged AuE/ SC/FA electrode
surface and (c) the corresponding impedance curves.
SC: Semiconductor; AuE: gold electrode; BSA: al-
bumin from bovine serum; CTC: circulating tumor
cells; FA: folic acid; NC: normal cells with low folic
receptor expression.
Fig. 2. Ultrasensitive cancer cell detection. (a)
Relative impedance at 10 Hz with time for AuE/
MoS2/FA electrodes scanned while being immersed
in HeLa cell with different concentrations in PBS. The
grey solid lines indicate fittings using exponential
association. (b) Calibration plots of relative im-
pedance at 10min for determining HeLa cells at AuE/
MoS2/FA electrodes while changing the concentra-
tion of HeLa cell in PBS. (c) Relative impedance at
10min at AuE/MoS2/FA electrodes for PBS, 10% FBS
solution, MC3T3-E1 cell suspension, HeLa cell sus-
pension and the mixture of all, indicating a good
selectivity of AuE/MoS2/FA electrodes. (d) Relative
impedance at 10min at AuE/MoS2/FA electrodes for
HeLa, MCF-7, MG-63 and SMMC-7721 cancer cell
suspensions. Three replicates were performed.
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τ2 are characteristic attachment and binding times, respectively. The
calculated rate constants for cell attachment and binding steps are
0.0065 s−1 and 0.02 s−1, respectively. Therefore, the cell attachment is
the control step, determining the measurement time. Fitting the all
impedance data to Eq. (1) yield the characteristic attachment times
τattach from 468 to 89 s and the binding times τbind from 133 to 4.3 s
with increasing HeLa cell concentration from 1 to 105 cell/mL, reaching
a final plateau approximately 10min, which was adopted in the fol-
lowing measurements.
Generally, increasing the concentration of HeLa cells led to faster
cell attachment and higher relative impedance, indicating that a higher
amount of HeLa cells were immobilized to the surface of the modified
electrode. It is not surprizing that the mean impedance against time was
dependent on the concentration of HeLa cells. The electrochemical
signal was directly related to the amount of cells attached on the surface
of the modified electrode. Amaingly, 1 cell/mL of concentration HeLa
cell could even be detected using our method (Fig. 2a). The increase of
relative impedance against time or cell numbers attached on the surface
of electrode is not a simple linear. The concentration of cells in this
research was increased from 10° to 105 by exponential increasing.
Therefore, the increase of relative impedance against the logarithm of
the cell number was linear. Fig. 2b shows the calibration plot of relative
impedance and logarithmic concentration, linear
(Z = 1.0128 + 0.0084 Log10 C, correlation coefficient of 0.9988) in the
concentration of HeLa cells from 1 to 105 cell/mL. The detection limit
for cell concentration was 0.43 cell/mL (signal to noise ratio is 3), the
detection limit of which was much lower than other reports (Table 1).
To explore the selectivity and anti-interference of AuE/MoS2/FA,
relative impedance values of AuE/MoS2/FA electrodes for PBS, 10%
fetal bovine serum (FBS) solution, MC3T3-E1 cell (FA-lack cell line)
suspension, HeLa cell suspension and the mixture of all were plotted
(Fig. 2c). Compared to buffer medium without any cells and MC3T3-E1
cell, relative impedance value of HeLa cell was much higher, which
almost approached relative impedance value of the mixture of all cell
suspensions, confirming its specificity to cancer cells (Fig. 2c and Fig.
S10). To further confirm the specificity of AuE/MoS2/FA to cancer cells,
the recognition event of few-layer MoS2 without FA was also in-
vestigated (Fig. S11). The ΔR value (1185 ± 35Ω) and relative im-
pedance of AuE/MoS2/FA for HeLa cell capturing was much higher
than that of AuE/MoS2/PVA without FA (195 ± 15Ω), further con-
firming the specificity of AuE/MoS2/FA to cancer cells. The similar
result is also obtained in glassy carbon electrode (GCE/MoS2/FA)
shown in Fig. S12. The ΔR value (1185Ω ± 35Ω) and relative im-
pedance of AuE/MoS2/FA for HeLa cell capturing were higher than that
of GCE/MoS2/FA (895Ω ± 25Ω). So AuE was used in the following
investigations.
In order to confirm that the universality of the proposed metho-
dology in electrochemical impedance detection of cells, the re-
presentative FR-riched cancer cell lines including MCF-7, MG-63 and
SMMC-7721 cell lines were investigated. In Fig. 2d, it can be seen that
the impedance responses at AuE/MoS2/FA electrodes were clearly ob-
served for all test cancer cell lines. This is mainly attributed to the
universal immobilization capacity of MoS2/FA interface for adhesion of
FR-rich cells. The difference of the impedance response at AuE/MoS2/
FA electrodes for different cell lines might be attributed to the different
amount of FR in different cancer cells.
3.3. Phase contrast microscopy characterization
To further confirm the fact that impedance increasing was really
resulted from HeLa cell capture and immobilization, the capture of
HeLa cells on the FA-modified electrode surface was further confirmed
by transmission-reflecting polarizing microscope (ECLIPSE/Ci-S,
Nikon) and phase contrast microscopy (Figs. S13a and b). In order to
further observe the cell capture on the electrode surface by phase
contrast microscopy, the optically transparent round coverslips (RCS,
φ14 mm) were used to replace the gold electrode because it is not
optically transparent. As indicated in Figs. S13b–h, with increasing
concentration of HeLa cell from 10 to 105 cell/mL, HeLa cells im-
mobilized on the MoS2/FA-coated slides increased, indicating that the
biosensing system had a good sensitivity, in good accordance with the
result of the EIS method. A large number of cells could be observed on
the surface of electrode when the MoS2/FA-coated slides were in-
cubated with HeLa cells (Fig. 3a). However, there were very few HeLa
cells on the surface of electrode when the FA-free MoS2/PVA-coated
slides were incubated with HeLa cells (Fig. 3b). These results indicate
that HeLa cells were effectively captured by FA molecules immobilized
on the RSC surface. The MoS2/FA-coated slides was also incubated with
FR-lack MC3T3-E1 cells, but only a few cells were adsorbed on the
surface of electrode (Fig. 3c), and almost no MC3T3-E1 cell was ob-
served on the surface of blank FA-free MoS2/PVA-coated slides
(Fig. 3d), suggesting the excellent selectivity of the MoS2/FA-coated
slides toward FR-rich cancer cells. The selective detection of HeLa cell
in the mixutre of HeLa and MC3T3-E1 cells suspension on MoS2/FA-
coated slides was further confirmed by fluorescence images (Figs. S14
and 15).
3.4. Detection mechanism
To further understand why our sensor is of high sensitivity, the 2D
materials with different electric conductivities were also investigated
under the similar conditions. For example, 2D MoS2 was displaced by
Table 1
Sensitivity of various nanomaterials-based cancer cell electrochemical biosensors.
Sensing element Cancer cell Transducer Linear range (cell/mL) LOD (cell/mL) Ref.
graphene HeLa EIS 103–106 794 Feng et al. (2011)
ECR HeLa DPV 10–106 10 Li et al. (2012b)
AuNP/FA HeLa EIS 6–103 and 103–105 6 Wang et al. (2012)
Ag@BSA composite KB EIS 6–108 20 Hu et al. (2013a)
Au/MPA/(Fc-PEI/ SWNT)5/FA HeLa DPV 10–106 10 Liu et al. (2013)
AuNPs/FA/ferrocene HeLa DPV 10–106 10 Xu et al. (2013)
GO/PLL K562 EIS 100–107 30 Zhang et al. (2013)
AuNPs-GA-CS HL-60 ECL 0–5.6×106 56 Feng et al. (2014)
Fe3O4@Au-aptamer HeLa ASV 160–15360 89 Jie et al. (2014)
Microfluidic paper HL-60 DPV 500–7.5× 107 350 Su et al. (2014)
TA/Au/ITO HeLa DPV 300–107 300 Wang et al. (2014)
BSA/Ag nanoflower DLD-1 EIS 135–1.35×107 40 Cao et al. (2015)
supersandwich G-quadruplex DNAzyme K562 DPV 14–14×106 14 Lu et al. (2015)
n-SiNPs/PPy SK-MEL-2 CV 25–3000 8 Seenivasan et al. (2015)
G-quadruplex/hemin/aptamer–AuNPs –HRP HepG2 DPV 102–107 6 Sun et al. (2015)
BDD/Au/MUA/FA HeLa EIS 10–105 10 Previous work (Weng et al., 2011)
MoS2/FA HeLa EIS 1–105 0.43 This work
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2D WS2, Bi2Se3, boron nitride (BN) and graphene to prepare WS2/FA,
Bi2Se3/FA, BN/FA and graphene/FA electrodes, respectively. The WS2/
FA, Bi2Se3/FA, graphene/FA and BN/FA were characterized well by
UV–vis spectra, XRD, Raman and AFM technologies (Figs. S16–19). Fig.
S20a shows that the relative impedance changes on other four elec-
trodes are smaller than that of AuE/MoS2/FA and the relative im-
pedance decreased in the following order (MoS2/FA > WS2/FA >
Bi2Se3/FA > graphene/FA > BN/FA, Fig. S20b). Interestingly, the
conductivity of these 2D materials increases in the following order:
BN < MoS2 < WS2<Bi2Se3 < graphene (Table S2). The con-
ductivity of cancer cell (0.13–0.23 S/m) is close to the conductivity of
MoS2 (0.14 S/m), which further confirms our hypothesis that the ex-
cellent conductivity matching of 2D semiconductor nanomaterials with
cancer cell would play an important role in ultrasensitive detection of
cancer cell. Therefore, ultrasensitive detection of tumor cells could be
owing to the following three aspects: firstly, 2D MoS2 with close elec-
tron conductivity to that of cancer cells might amplify the impedance
change after a few cancer cells were anchored. Secondly, the high FA
loading of MoS2/FA might make sure that even just a few cancer cell
could be captured efficiently by our MoS2/FA, resulting the impedance
increasing obviously. Thirdly, the 2D nanosheet structure of MoS2/FA
with high specific surface area might boost the contact sites between 2D
semiconductors and cancer cells, thus enhancing the detection sensi-
tivity. At the same time, the high sensivity of this sensor could also be
attributed to the field effect and surface charge density change induced
by high negative charges in cell membrane of cancer cells (Li et al.,
2014; Siek et al., 2018; Weng et al., 2008).
3.5. Application for clinical sample analysis
To explore the feasibility of the developed strategy in biological
media, the as-prepared cytosensor was used to detect HeLa cells in
human serum. Learned from curve (b) in Fig. 4, the relative resistance
at 10min linearly increased with logarithm of cancer cell concentration
from 50 to 105 cells/mL by fitting (ΔZ=0.0264 Log10C, correlation
coefficient of 0.98), with a detection limit of 52.24 cell/mL (S/N=2),
demonstrating the feasibility of the developed strategy for the analysis
of real clinical sample. In general, most of the impedance biosensors
developed and tested are suffered from complex matrix presented in
clinical samples, thus limiting the successful implication of the im-
pedance biosensors for clinical application. To ultimately verify the
performance of the proposed biosensor, sixteen clinically acquired
samples (four liver cancers, four cervical cancers and 8 healthy people)
from the First Hospital of Xiamen University were tested. The detailed
experiments were listed in the experimental section and the results
were shown in Fig. 4c and d. The relative impedance experienced a
large jump when whole blood of cancer patient was added, which was
higher than that of healthy people and PBS (Fig. 4c) and the relative
impedances measured from cancer patients were significantly higher
than those of normal controls (Fig. 4d), indicating that the biosensing
could distinguish cancer patients from normal individuals. CTCs were
identified in all cervical and liver cancer patients, ranging from 5 to 100
CTCs/mL by flow cytometry offered by the hospital. Interstingly, by
using our EIS stratagy, 37.3 ± 2.4 cervical CTCs/mL, 47.2 ± 1.8 liver
CTCs/mL but almost no CTCs (mean=1 ± 0.2 CTCs/mL) in hyper-
plastic prostate donors and healthy controls were obtained, respec-
tively. This result strongly support that the present approach might be
suitable for detection of FR-rich CTC in cancer patients.
4. Conclusion
In summary, we have demonstrated an MoS2/FA-based label-free
electrochemical impedance stratagy for cancer cells detection with a
linear detection range from 1 to 105 cell/mL and a detection limit of
0.43 cell/mL (S/N=3). The optimized electrode shows good selec-
tively, universality, and anti-interference for FR-rich cancer cells. The
high sensitivity might be attributed to electric conductivity matching of
2D MoS2 semiconductor to cancer cells. Furthermore, the biosensor
could effectively differentiate tumor samples from normal controls.
Though the molecular understanding of detection mechanism and
practical clinical application is limited, which will be discussed in our
future work and extending the concept of 2D semiconductor con-
ductivity matching for DNA and other cancer biomarkers detection as
well.
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